Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
COARE Biotechnology logo — Pioneering targeted therapies to eradicate solid tumor cance...

COARE Biotechnology

Pioneering targeted therapies to eradicate solid tumor cancers and alleviate patient suffering worldwide.

Founded 2013 3 employees Grant Total: $220.10K Biotechnology, Health Care +1

General Information

Company Name COARE Biotechnology
Founded Year 2013
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with COARE Biotechnology. To contact COARE Biotechnology, visit coarebiotechnology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does COARE Biotechnology compare?

A PDF of COARE Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting COARE Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About COARE Biotechnology

COARE Biotechnology is a pioneering biotechnology company founded in 2013 with a mission to eradicate solid tumor cancers and alleviate patient suffering worldwide. The company's multidisciplinary approach focuses on advancing the current treatment modality for aggressive cancers by targeting aspects of both the primary tumor and the biological processes that affect metastatic initiation and progression. COARE Biotechnology has gained worldwide acclaim for its groundbreaking scientific discoveries, leading to the development of novel therapeutic platforms and the identification of key components within cancer biology that have not been targeted until now. The company operates in the Biotechnology, Health Care, and Health and Wellness industries. COARE Biotechnology received a grant investment of $220.10K on 27 August 2013. As a Venture Capital firm, investing in COARE Biotechnology presents an opportunity to support a company at the forefront of developing targeted therapies for aggressive cancers, potentially revolutionizing cancer treatment. With its innovative approach and strong scientific foundation, COARE Biotechnology is positioned to make a significant impact in the field of cancer research and treatment.

Business keywords: targeted therapies, solid tumor cancer, tumor-initiating cells, cancer research, tissue stem/progenitor cells, xenograft models, mouse cancer stem cell line, therapeutic targets, monoclonal antibodies, siRNA delivery platform, stem cell biology, regulatory mechanisms, biological pathways, cancer stem cell fate, patient suffering alleviation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $220.10K -
27 Aug 2013

COARE Biotechnology Alternatives & Competitors

View All Alternatives
COARE Biotechnology vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care
COARE Biotechnology vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
COARE Biotechnology vs
Kinnate Biopharma Inc.
Kinnate Biopharma Inc. United States

Inspiring Hope to Those Battling Cancer

Acquired
10 employees
Biopharma, Biotechnology
View all alternatives

FAQ About COARE Biotechnology

Pioneering targeted therapies to eradicate solid tumor cancers and alleviate patient suffering worldwide.
COARE Biotechnology was founded in 2013.
COARE Biotechnology operates in Biotechnology, Health Care and Health and Wellness. Its work centres on targeted therapies, solid tumor cancer, tumor-initiating cells and cancer research.
COARE Biotechnology has approximately 3 employees.
COARE Biotechnology has completed 1 funding round, raising a total of $220.10K. The latest funding stage is Grant.
Top alternatives and competitors to COARE Biotechnology include Apollomics, Prescient Therapeutics, Kinnate Biopharma Inc., Surface Oncology Inc., Celldom, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
COARE Biotechnology and Apollomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for COARE Biotechnology, https://bouncewatch.com/company/coare-biotechnology, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout